Vicora, Inc. has filed a notice of an exempt offering of securities to raise $6 Million in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Vicora, Inc. is raising up to $6,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Vicora, Inc.
Headquartered in Buffalo, New York, Vicora is the first portfolio company of Egret Healthcare Ventures. Founded to help create a sustainable start up ecosystem that fosters medical device innovation, Egret Healthcare Ventures includes a seasoned group of partners across finance, healthcare, innovation, product development and the regulatory world. They have a strong track record of successful startup business creation, advancement and exits. Working collaboratively with regional strengths and centers of excellence, Egret Healthcare Ventures is building a disruptive portfolio of innovative companies driven by clinical and technological advancement.
To learn more about Vicora, Inc., visit https://www.vicora.net/
Vicora, Inc. Linkedin Page: https://www.linkedin.com/company/vicora-inc/
Contact:
Matthew Colpoys, Chief Financial Officer
716-536-2971
https://www.linkedin.com/in/matthew-colpoys-a8a3584/
SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.